Cargando…
A comparison of (64)Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin α(ν)β(6)
Expression of epithelial-specific integrin α(ν)β(6) is up-regulated in various aggressive cancers and serves as a prognostic marker. Integrin-targeted PET imaging probes have been successfully developed and tested in the clinic. Radiotracers based on the peptide A20FMDV2 derived from foot-and-mouth...
Autores principales: | Huynh, Truc T., Sreekumar, Sreeja, Mpoy, Cedric, Rogers, Buck E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849274/ https://www.ncbi.nlm.nih.gov/pubmed/35186193 http://dx.doi.org/10.18632/oncotarget.28197 |
Ejemplares similares
-
Therapeutic Efficacy of (177)Lu-Labeled A20FMDV2 Peptides Targeting α(ν)β(6)
por: Huynh, Truc Thao, et al.
Publicado: (2022) -
Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer
por: Huynh, Truc T., et al.
Publicado: (2022) -
Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer
por: Sreekumar, Sreeja, et al.
Publicado: (2023) -
Use of Protein Pegylation to Prolong the Antiviral Effect of IFN Against FMDV
por: Diaz-San Segundo, Fayna, et al.
Publicado: (2021) -
First-in-Humans Evaluation of Safety and Dosimetry of (64)Cu-LLP2A for PET Imaging
por: Laforest, Richard, et al.
Publicado: (2023)